Human free apolipoprotein A-I and artificial pre-beta-high-density lipoprotein inhibit eNOS activity and NO release

Biochimica Et Biophysica Acta
Olivier BriandPatrick Duriez

Abstract

Little is known about the effects of human free apolipoprotein A-I (Free-Apo A-I) and pre-beta-high density lipoprotein (pre-beta-HDL) on the endothelium function. In this study, we have investigated the effects of Free-Apo A-I and artificial pre-beta-HDL on endothelial NO synthase (eNOS) activity and on NO production by endothelial cells. Free-Apo A-I drastically inhibited NO production in human umbilical cord vein endothelial cells (HUVECs) and eNOS activity in bovine aortic endothelial cells (BAECs). Pre-beta-HDL and serum from human apolipoprotein A-I transgenic rabbits inhibited eNOS activity in BAECs but HDL3 did not. Free-Apo A-I displaced eNOS from BAEC plasma membrane towards intracellular pools without affecting eNOS activity and eNOS mass in BAEC crude homogenates. Free-Apo A-I and HDL3 did not decrease either caveolin bound to BAEC plasma membrane or caveola cholesterol content. As previously described, we showed that HDL3 directly induced endothelium-dependent relaxation of rings from rat aorta. We observed that pre-beta-HDL significantly decreased endothelium-dependent relaxation of rat aortic rings ex vivo.

References

Jan 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·D S Bredt, S H Snyder
Dec 1, 1991·Metabolism: Clinical and Experimental·G LucJ Davignon
Nov 7, 1995·Biochemistry·P E Fielding, C J Fielding
Mar 10, 1995·The Journal of Biological Chemistry·D L SparksM C Phillips
Feb 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·M S ShearmanL L Iversen
Oct 1, 1995·European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies·T HayekM Aviram
Dec 1, 1996·Arteriosclerosis, Thrombosis, and Vascular Biology·N DuvergerP Denèfie
Feb 12, 1998·Biochemical and Biophysical Research Communications·G LebuffeP Duriez
Mar 4, 1999·Clinica Chimica Acta; International Journal of Clinical Chemistry·F D BritesG R Castro
May 3, 2000·Journal of Internal Medicine·J E Tooke, M M Hannemann
Oct 12, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·C NapoliW Palinski
May 17, 2003·The Journal of Clinical Investigation·Ming GongEric J Smart
Sep 1, 1955·The Journal of Clinical Investigation·R J HAVELJ H BRAGDON

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Caveolins & Signal Transduction

Caveolins are small proteins with a hairpin loop conformation that are located in the plasma membrane of various cell types where they bind cholesterol and interact with receptors essential for several signal transduction pathways. Here is the latest research.